During the routine follow-up of adult patients with pulmonary arterial hypertension associated with atrial septal defects (ASD-PAH), the suitability of shunt closure depends on the invasive right heart catheterization (RHC). It is difficult to grasp the timing of RHC shunt closure for moderate-severe PAH. This retrospective cross-sectional study was designed to investigate which echocardiographic variables are related to pulmonary vascular resistance (PVR) in adult ASD-PAH patients and propose a method using echocardiographic variables to screen for patients where shunt closure is suitable. A total of 139 adult ASD-PAH patients with a PASP ≥ 60 mmHg measured by transthoracic echocardiogram (TTE) were included in this study. All RHCs were performed within a week after TTE. The Correctable shunt was defined as PVR ≤ 4.6 wood units (WU). Multivariate regressions were performed with echocardiographic variables. The nomogram of prediction model was constructed by the predictors of PVR ≤ 4.6 WU by multivariate logistic regression analysis. Multivariate linear regression revealed that TAPSE (tricuspid annular plane systolic excursion)/pulmonary artery systolic pressure (PASP) measured by TTE was negatively associated with PVR (β per SD: − 1.84, 95%CI − 2.62, − 1.06). Multivariate logistic regression showed that TAPSE/PASP and pulmonary valve (PV) peak velocity were positively associated with a potentially correctable shunt (PVR ≤ 4.6 WU) (OR per SD: 2.38, 95%CI 1.34, 4.25, and OR per SD: 2.67, 95%CI 1.26, 5.64, respectively). In receiver operating characteristic analysis, the TAPSE/PASP + PV peak velocity combined model achieved the best performance (AUC: 0.8584, sensitivity: 83.33%, specificity: 72.16%). Internal verification showed stable performance (AUC: 0.8591, sensitivity: 88.10%, specificity: 68.04%). The net benefit of this model was greater than other models when it came to a wide range probability threshold in decision curve analysis. TAPSE/PASP + PV the peak velocity model may have great value in predicting adult ASD-PAH patients with operability potential, which could help clinicians make the treatment decision for follow-up patients.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Availability of data and materials
The data that support the findings of this study are available on request. The data are not publicly available due to the containing information that could compromise the privacy of research participants.
Atrial septal defect
Pulmonary arterial systolic pressure
Pulmonary arterial hypertension
Pulmonary vascular resistance
Right heart catheterization
Right ventricular outflow tract diameter
Tricuspid annular plane systolic excursion
Peak velocity of tricuspid regurgitation
- TV s’:
Systolic annular tissue velocity of the lateral tricuspid annulus
Chelu RG, Horowitz M, Sucha D, Kardys I, Ingremeau D, Vasanawala S, Nieman K, Paul JF, Hsiao A (2019) Evaluation of atrial septal defects with 4D flow MRI-multilevel and inter-reader reproducibility for quantification of shunt severity. Magma (New York, NY) 32(2):269–279. https://doi.org/10.1007/s10334-018-0702-z
Engelfriet PM, Duffels MG, Möller T, Boersma E, Tijssen JG, Thaulow E, Gatzoulis MA, Mulder BJ (2007) Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart 93(6):682–687. https://doi.org/10.1136/hrt.2006.098848
Vongpatanasin W, Brickner ME, Hillis LD, Lange RA (1998) The Eisenmenger syndrome in adults. Ann Intern Med 128(9):745–755. https://doi.org/10.7326/0003-4819-128-9-199805010-00008
Jain S, Dalvi B (2018) Atrial septal defect with pulmonary hypertension: when/how can we consider closure? J Thorac Dis 10(Suppl 24):S2890-s2898. https://doi.org/10.21037/jtd.2018.07.112
Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF (2019) 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139(14):e698–e800. https://doi.org/10.1161/cir.0000000000000603
Guazzi M, Bandera F, Pelissero G, Castelvecchio S, Menicanti L, Ghio S, Temporelli PL, Arena R (2013) Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol 305(9):H1373-1381. https://doi.org/10.1152/ajpheart.00157.2013
Chan KL (2007) The Ultimate Echo Guide. In: Can J Cardiol, vol 23. vol 6. © 2007, Pulsus Group Inc. All rights reserved., p 456
Condliffe R, Clift P, Dimopoulos K, Tulloh RMR (2018) Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease. Pulmonary circulation 8(3):2045894018792501. https://doi.org/10.1177/2045894018792501
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67–119. https://doi.org/10.1093/eurheartj/ehv317
Caojin Z, Yigao H, Tao H, Wenhui H, Chunli X, Xinsheng H (2012) Comparison of acute hemodynamic effects of aerosolized iloprost and inhaled nitric oxide in adult congenital heart disease with severe pulmonary arterial hypertension. Internal medicine (Tokyo, Japan) 51(20):2857–2862. https://doi.org/10.2169/internalmedicine.51.7927
Bandos AI, Rockette HE, Song T, Gur D (2009) Area under the free-response ROC curve (FROC) and a related summary index. Biometrics 65(1):247–256. https://doi.org/10.1111/j.1541-0420.2008.01049.x
Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ (Clinical research ed) 350:g7594. https://doi.org/10.1136/bmj.g7594
Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ (2003) A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 41(6):1021–1027. https://doi.org/10.1016/s0735-1097(02)02973-x
Ajami GH, Cheriki S, Amoozgar H, Borzouee M, Soltani M (2011) Accuracy of Doppler-derived estimation of pulmonary vascular resistance in congenital heart disease: an index of operability. Pediatr Cardiol 32(8):1168–1174. https://doi.org/10.1007/s00246-011-0035-4
Dahiya A, Vollbon W, Jellis C, Prior D, Wahi S, Marwick T (2010) Echocardiographic assessment of raised pulmonary vascular resistance: application to diagnosis and follow-up of pulmonary hypertension. Heart 96(24):2005–2009. https://doi.org/10.1136/hrt.2010.204834
Kouzu H, Nakatani S, Kyotani S, Kanzaki H, Nakanishi N, Kitakaze M (2009) Noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. Am J Cardiol 103(6):872–876. https://doi.org/10.1016/j.amjcard.2008.11.039
Pande A, Sarkar A, Ahmed I, Naveen Chandra G, Patil SK, Kundu CK, Arora R, Samanta A (2014) Non-invasive estimation of pulmonary vascular resistance in patients of pulmonary hypertension in congenital heart disease with unobstructed pulmonary flow. Ann Pediatr Cardiol 7(2):92–97. https://doi.org/10.4103/0974-2069.132475
Roule V, Labombarda F, Pellissier A, Sabatier R, Lognoné T, Gomes S, Bergot E, Milliez P, Grollier G, Saloux E (2010) Echocardiographic assessment of pulmonary vascular resistance in pulmonary arterial hypertension. Cardiovasc Ultrasound 8:21. https://doi.org/10.1186/1476-7120-8-21
Vlahos AP, Feinstein JA, Schiller NB, Silverman NH (2008) Extension of Doppler-derived echocardiographic measures of pulmonary vascular resistance to patients with moderate or severe pulmonary vascular disease. J Am Soc Echocardiogr 21(6):711–714. https://doi.org/10.1016/j.echo.2007.10.004
Steiner J, Wu WC, Jankowich M, Maron BA, Sharma S, Choudhary G (2015) Echocardiographic predictors of mortality in patients with pulmonary hypertension and cardiopulmonary comorbidities. PLoS ONE 10(3):e0119277. https://doi.org/10.1371/journal.pone.0119277
Tello K, Axmann J, Ghofrani HA, Naeije R, Narcin N, Rieth A, Seeger W, Gall H, Richter MJ (2018) Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension. Int J Cardiol 266:229–235. https://doi.org/10.1016/j.ijcard.2018.01.053
Guazzi M, Naeije R, Arena R, Corrà U, Ghio S, Forfia P, Rossi A, Cahalin LP, Bandera F, Temporelli P (2015) Echocardiography of right ventriculoarterial coupling combined with cardiopulmonary exercise testing to predict outcome in heart failure. Chest 148(1):226–234. https://doi.org/10.1378/chest.14-2065
Bosch L, Lam CSP, Gong L, Chan SP, Sim D, Yeo D, Jaufeerally F, Leong KTG, Ong HY, Ng TP, Richards AM, Arslan F, Ling LH (2017) Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction. Eur J Heart Fail 19(12):1664–1671. https://doi.org/10.1002/ejhf.873
Tello K, Wan J, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, Roller F, Mohajerani E, Seeger W, Herberg U, Sommer N, Gall H, Richter MJ (2019) Validation of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio for the assessment of right ventricular-arterial coupling in severe pulmonary hypertension. Circ Cardiovasc Imaging 12(9):e009047. https://doi.org/10.1161/circimaging.119.009047
Sommer RJ, Hijazi ZM, Rhodes JF Jr (2008) Pathophysiology of congenital heart disease in the adult: part I: Shunt lesions. Circulation 117(8):1090–1099. https://doi.org/10.1161/circulationaha.107.714402
This work was supported by Guangdong Provincial People's Hospital Hospital Science and Technology Special Project (No. 2017zh04); Guangzhou Science and Technology Key Project , National key Research and Development Program of China [2018YFC1002600], the Natural Science Foundation of Guangdong Province [2018A030313785, 2018A030313764], the Science and Technology Planning Project of Guangdong Province, China [No.2017A070701013, 2017B090904034, 2017B030314109, 2018B090944002, 2019B020230003], and Guangdong Peak Project [DFJH201802].
The Authors declare that there is no conflict of interest.
This study was approved by the Research Ethics Committee of Guangdong General Hospital, Guangdong, China on 24 July 2015 (No. GDREC2015254H(R1)). We further confirm that any aspect of the data collection covered in this manuscript that has involved our patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript.
Consent for publication
We guarantee that the contribution to the work has not been previously published elsewhere, or that if it has been published in whole or in part, any permission necessary to publish it in the work has been obtained.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Li, M., Wang, Y., Li, H. et al. A prediction model of simple echocardiographic variables to screen for potentially correctable shunts in adult patients with pulmonary arterial hypertension associated with atrial septal defects: a cross-sectional study. Int J Cardiovasc Imaging (2021). https://doi.org/10.1007/s10554-020-02128-5
- Pulmonary arterial hypertension
- Atrial septal defect
- Pulmonary vascular resistance